Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Broad-spectrum capture of clinical pathogens using engineered Fc-mannose-binding lectin enhanced by antibiotic treatment.

Seiler BT, Cartwright M, Dinis ALM, Duffy S, Lombardo P, Cartwright D, Super EH, Lanzaro J, Dugas K, Super M, Ingber DE.

F1000Res. 2019 Jan 25;8:108. doi: 10.12688/f1000research.17447.1. eCollection 2019.

2.

Evaluation of Mannose Binding Lectin Gene Variants in Pediatric Influenza Virus-Related Critical Illness.

Levy ER, Yip WK, Super M, Ferdinands JM, Mistry AJ, Newhams MM, Zhang Y, Su HC, McLaughlin GE, Sapru A, Loftis LL, Weiss SL, Hall MW, Cvijanovich N, Schwarz A, Tarquinio KM, Mourani PM; PALISI PICFLU Investigators, Randolph AG.

Front Immunol. 2019 May 8;10:1005. doi: 10.3389/fimmu.2019.01005. eCollection 2019.

3.

Species-specific enhancement of enterohemorrhagic E. coli pathogenesis mediated by microbiome metabolites.

Tovaglieri A, Sontheimer-Phelps A, Geirnaert A, Prantil-Baun R, Camacho DM, Chou DB, Jalili-Firoozinezhad S, de Wouters T, Kasendra M, Super M, Cartwright MJ, Richmond CA, Breault DT, Lacroix C, Ingber DE.

Microbiome. 2019 Mar 20;7(1):43. doi: 10.1186/s40168-019-0650-5.

4.

A Broad-Spectrum Infection Diagnostic that Detects Pathogen-Associated Molecular Patterns (PAMPs) in Whole Blood.

Cartwright M, Rottman M, Shapiro NI, Seiler B, Lombardo P, Gamini N, Tomolonis J, Watters AL, Waterhouse A, Leslie D, Bolgen D, Graveline A, Kang JH, Didar T, Dimitrakakis N, Cartwright D, Super M, Ingber DE.

EBioMedicine. 2016 Jul;9:217-227. doi: 10.1016/j.ebiom.2016.06.014. Epub 2016 Jun 13.

5.

Rapid Isolation of Staphylococcus aureus Pathogens from Infected Clinical Samples Using Magnetic Beads Coated with Fc-Mannose Binding Lectin.

Bicart-See A, Rottman M, Cartwright M, Seiler B, Gamini N, Rodas M, Penary M, Giordano G, Oswald E, Super M, Ingber DE.

PLoS One. 2016 Jun 8;11(6):e0156287. doi: 10.1371/journal.pone.0156287. eCollection 2016.

6.

Purified and Recombinant Hemopexin: Protease Activity and Effect on Neutrophil Chemotaxis.

Lin T, Liu J, Huang F, Engelen TSV, Thundivalappil SR, Riley FE, Super M, Watters AL, Smith A, Brinkman N, Ingber DE, Warren HS.

Mol Med. 2016 Sep;22:22-31. doi: 10.2119/molmed.2016.00006. Epub 2016 Jan 8.

7.

Optimization of Pathogen Capture in Flowing Fluids with Magnetic Nanoparticles.

Kang JH, Um E, Diaz A, Driscoll H, Rodas MJ, Domansky K, Watters AL, Super M, Stone HA, Ingber DE.

Small. 2015 Nov 11;11(42):5657-66. doi: 10.1002/smll.201501820. Epub 2015 Sep 21.

PMID:
26389806
8.

Improved treatment of systemic blood infections using antibiotics with extracorporeal opsonin hemoadsorption.

Didar TF, Cartwright MJ, Rottman M, Graveline AR, Gamini N, Watters AL, Leslie DC, Mammoto T, Rodas MJ, Kang JH, Waterhouse A, Seiler BT, Lombardo P, Qendro EI, Super M, Ingber DE.

Biomaterials. 2015 Oct;67:382-92. doi: 10.1016/j.biomaterials.2015.07.046. Epub 2015 Jul 26.

PMID:
26253638
9.

A bioinspired omniphobic surface coating on medical devices prevents thrombosis and biofouling.

Leslie DC, Waterhouse A, Berthet JB, Valentin TM, Watters AL, Jain A, Kim P, Hatton BD, Nedder A, Donovan K, Super EH, Howell C, Johnson CP, Vu TL, Bolgen DE, Rifai S, Hansen AR, Aizenberg M, Super M, Aizenberg J, Ingber DE.

Nat Biotechnol. 2014 Nov;32(11):1134-40. doi: 10.1038/nbt.3020. Epub 2014 Oct 12.

PMID:
25306244
10.

An extracorporeal blood-cleansing device for sepsis therapy.

Kang JH, Super M, Yung CW, Cooper RM, Domansky K, Graveline AR, Mammoto T, Berthet JB, Tobin H, Cartwright MJ, Watters AL, Rottman M, Waterhouse A, Mammoto A, Gamini N, Rodas MJ, Kole A, Jiang A, Valentin TM, Diaz A, Takahashi K, Ingber DE.

Nat Med. 2014 Oct;20(10):1211-6. doi: 10.1038/nm.3640. Epub 2014 Sep 14.

PMID:
25216635
11.

Stationary nanoliter droplet array with a substrate of choice for single adherent/nonadherent cell incubation and analysis.

Shemesh J, Ben Arye T, Avesar J, Kang JH, Fine A, Super M, Meller A, Ingber DE, Levenberg S.

Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11293-8. doi: 10.1073/pnas.1404472111. Epub 2014 Jul 22.

12.

A microdevice for rapid optical detection of magnetically captured rare blood pathogens.

Cooper RM, Leslie DC, Domansky K, Jain A, Yung C, Cho M, Workman S, Super M, Ingber DE.

Lab Chip. 2014 Jan 7;14(1):182-8. doi: 10.1039/c3lc50935d.

PMID:
24169822
13.

Scalable gene synthesis by selective amplification of DNA pools from high-fidelity microchips.

Kosuri S, Eroshenko N, Leproust EM, Super M, Way J, Li JB, Church GM.

Nat Biotechnol. 2010 Dec;28(12):1295-9. doi: 10.1038/nbt.1716. Epub 2010 Nov 28.

14.

The potential for cancer combination therapy with multi-targeted, single-protein pharmaceuticals.

Way J, Super M.

Expert Opin Drug Discov. 2008 Feb;3(2):147-52. doi: 10.1517/17460441.3.2.147.

PMID:
23480218
15.

A novel 5q11.2 deletion detected by microarray comparative genomic hybridisation in a child referred as a case of suspected 22q11 deletion syndrome.

Prescott K, Woodfine K, Stubbs P, Super M, Kerr B, Palmer R, Carter NP, Scambler P.

Hum Genet. 2005 Jan;116(1-2):83-90. Epub 2004 Nov 10.

PMID:
15549396
16.

Blood pressure and the cystic fibrosis gene: evidence for lower pressure rises with age in female carriers.

Super M, Irtiza-Ali A, Roberts SA, Schwarz M, Young M, Smith A, Roberts T, Hinks J, Heagerty A.

Hypertension. 2004 Dec;44(6):878-83. Epub 2004 Oct 11.

PMID:
15477385
17.

Case 4: assessment. An adolescent aged 14 has cystic fibrosis.

Roberts T, Schwarz MJ, Kerr-Liddell R, Hinks JL, Super M.

Paediatr Respir Rev. 2003 Dec;4(4):348, 350. No abstract available.

PMID:
14692404
18.

Cascade carrier-testing in cystic fibrosis.

Roberts T, Schwarz MJ, Kerr-Liddell R, Hinks JL, Super M.

Paediatr Respir Rev. 2003 Dec;4(4):293-8.

PMID:
14629951
19.

Cystic fibrosis newborn screening and detection of carriers.

Super M.

Arch Dis Child Fetal Neonatal Ed. 2003 Nov;88(6):F448-9. No abstract available.

20.

End-organ dysfunction in cystic fibrosis: association with angiotensin I converting enzyme and cytokine gene polymorphisms.

Arkwright PD, Pravica V, Geraghty PJ, Super M, Webb AK, Schwarz M, Hutchinson IV.

Am J Respir Crit Care Med. 2003 Feb 1;167(3):384-9.

PMID:
12554626
22.

Bone status in cystic fibrosis.

Sood M, Hambleton G, Super M, Fraser WD, Adams JE, Mughal MZ.

Arch Dis Child. 2001 Jun;84(6):516-20.

23.

Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein.

Watson P, Black G, Ramsden S, Barrow M, Super M, Kerr B, Clayton-Smith J.

J Med Genet. 2001 Apr;38(4):224-8.

24.

Clinical studies on submicroscopic subtelomeric rearrangements: a checklist.

de Vries BB, White SM, Knight SJ, Regan R, Homfray T, Young ID, Super M, McKeown C, Splitt M, Quarrell OW, Trainer AH, Niermeijer MF, Malcolm S, Flint J, Hurst JA, Winter RM.

J Med Genet. 2001 Mar;38(3):145-50.

25.
26.

Sibs with developmental delay, hirsutism and nail hypoplasia: a new syndrome.

Stewart H, Kerr B, Tomlin P, Stacey D, Super M.

Clin Dysmorphol. 2000 Oct;9(4):241-6.

PMID:
11045578
27.

Phenotypic variability and asymmetry of Rieger syndrome associated with PITX2 mutations.

Perveen R, Lloyd IC, Clayton-Smith J, Churchill A, van Heyningen V, Hanson I, Taylor D, McKeown C, Super M, Kerr B, Winter R, Black GC.

Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2456-60.

PMID:
10937553
28.

CFTR and disease: implications for drug development.

Super M.

Lancet. 2000 May 27;355(9218):1840-2. No abstract available.

PMID:
10866434
29.

TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis.

Arkwright PD, Laurie S, Super M, Pravica V, Schwarz MJ, Webb AK, Hutchinson IV.

Thorax. 2000 Jun;55(6):459-62.

30.

Polytopic anomalies with agenesis of the lower vertebral column.

Bohring A, Lewin SO, Reynolds JF, Voigtländer T, Rittinger O, Carey JC, Köpernik M, Smith R, Zackai EH, Leonard NJ, Gritter HL, Bamforth JS, Okun N, McLeod DR, Super M, Powell P, Mundlos S, Hennekam RC, van Langen IM, Viskochil DH, Wiedemann HR, Opitz JM.

Am J Med Genet. 1999 Nov 19;87(2):99-114. Review.

PMID:
10533024
31.

Pharmacokinetics and stability of the ch14.18-interleukin-2 fusion protein in mice.

Kendra K, Gan J, Ricci M, Surfus J, Shaker A, Super M, Frost JD, Rakhmilevich A, Hank JA, Gillies SD, Sondel PM.

Cancer Immunol Immunother. 1999 Aug;48(5):219-29.

PMID:
10478638
32.

Can manifesting heterozygotes have cystic fibrosis?

Super M.

Thorax. 1999 Mar;54(3):194-5. No abstract available.

33.

Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptors.

Gillies SD, Lan Y, Lo KM, Super M, Wesolowski J.

Cancer Res. 1999 May 1;59(9):2159-66.

34.
35.

A clinical study of type 1 neurofibromatosis in north west England.

McGaughran JM, Harris DI, Donnai D, Teare D, MacLeod R, Westerbeek R, Kingston H, Super M, Harris R, Evans DG.

J Med Genet. 1999 Mar;36(3):197-203.

36.

DeltaF508 heterozygosity and asthma.

Super M, Hambleton G, Corbett D.

Lancet. 1998 Sep 19;352(9132):986. No abstract available.

PMID:
9752841
37.

The use of human glutathione S-transferase A1 in the detection of cystic fibrosis liver disease.

Hung JC, Howie AF, Beckett GJ, Sood M, Hambleton G, Super M.

J Paediatr Child Health. 1998 Aug;34(4):335-8.

PMID:
9727173
38.

Mutations of the cystic fibrosis gene in patients with chronic pancreatitis.

Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, Braganza J.

N Engl J Med. 1998 Sep 3;339(10):645-52.

39.

Genetic advances in cystic fibrosis: to screen, to treat or both?

Super M, Abbott J.

Disabil Rehabil. 1998 Jun-Jul;20(6-7):202-8. Review.

PMID:
9637928
40.

Antibody-IL-12 fusion proteins are effective in SCID mouse models of prostate and colon carcinoma metastases.

Gillies SD, Lan Y, Wesolowski JS, Qian X, Reisfeld RA, Holden S, Super M, Lo KM.

J Immunol. 1998 Jun 15;160(12):6195-203.

41.

Anaesthesia and Prader-Willi syndrome.

Dearlove OR, Dobson A, Super M.

Paediatr Anaesth. 1998;8(3):267-71.

PMID:
9608976
42.

Velocardiofacial syndrome.

Pike AC, Super M.

Postgrad Med J. 1997 Dec;73(866):771-5. Review.

43.

Confidential inquiry into families with two siblings with cystic fibrosis.

Lane B, Williamson P, Dodge JA, Harris H, Super M, Harris R.

Arch Dis Child. 1997 Dec;77(6):501-3.

45.

Macrocephaly with cutis marmorata, haemangioma and syndactyly--a distinctive overgrowth syndrome.

Clayton-Smith J, Kerr B, Brunner H, Tranebjaerg L, Magee A, Hennekam RC, Mueller RF, Brueton L, Super M, Steen-Johnsen J, Donnai D.

Clin Dysmorphol. 1997 Oct;6(4):291-302.

PMID:
9354837
46.

Elimination of established murine colon carcinoma metastases by antibody-interleukin 2 fusion protein therapy.

Xiang R, Lode HN, Dolman CS, Dreier T, Varki NM, Qian X, Lo KM, Lan Y, Super M, Gillies SD, Reisfeld RA.

Cancer Res. 1997 Nov 1;57(21):4948-55.

47.

Familial patent ductus arteriosus: a further case of CHAR syndrome.

Slavotinek A, Clayton-Smith J, Super M.

Am J Med Genet. 1997 Aug 8;71(2):229-32.

PMID:
9217229
48.

Genes, familial enuresis, and clinical management.

Super M, Postlethwaite RJ.

Lancet. 1997 Jul 19;350(9072):159-60. No abstract available.

PMID:
9250180
49.

Cystic fibrosis mutations in Romania.

Popa I, Pop L, Popa Z, Schwarz MJ, Hambleton G, Malone GM, Haworth A, Super M.

Eur J Pediatr. 1997 Mar;156(3):212-3.

PMID:
9083763
50.

Novel and recurrent mutations in the neurofibromatosis type 1 (NF1) gene.

Hudson J, Wu CL, Tassabehji M, Summers EM, Simon S, Super M, Donnai D, Thakker N.

Hum Mutat. 1997;9(4):366-7. No abstract available.

PMID:
9101300

Supplemental Content

Support Center